nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—ABCC2—Carboplatin—bone cancer	0.231	0.276	CbGbCtD
Levetiracetam—ABCC2—Cisplatin—bone cancer	0.197	0.236	CbGbCtD
Levetiracetam—ABCC2—Doxorubicin—bone cancer	0.132	0.158	CbGbCtD
Levetiracetam—ABCC2—Methotrexate—bone cancer	0.128	0.153	CbGbCtD
Levetiracetam—ABCB1—Cisplatin—bone cancer	0.0642	0.0768	CbGbCtD
Levetiracetam—ABCB1—Doxorubicin—bone cancer	0.0431	0.0515	CbGbCtD
Levetiracetam—ABCB1—Methotrexate—bone cancer	0.0417	0.0498	CbGbCtD
Levetiracetam—Dehydration—Epirubicin—bone cancer	0.00049	0.003	CcSEcCtD
Levetiracetam—Skin disorder—Cisplatin—bone cancer	0.000489	0.003	CcSEcCtD
Levetiracetam—Hyponatraemia—Doxorubicin—bone cancer	0.000489	0.00299	CcSEcCtD
Levetiracetam—Diplopia—Doxorubicin—bone cancer	0.000487	0.00298	CcSEcCtD
Levetiracetam—Asthma—Methotrexate—bone cancer	0.000486	0.00298	CcSEcCtD
Levetiracetam—Liver function test abnormal—Epirubicin—bone cancer	0.000486	0.00298	CcSEcCtD
Levetiracetam—Eosinophilia—Methotrexate—bone cancer	0.000481	0.00295	CcSEcCtD
Levetiracetam—Abdominal pain upper—Epirubicin—bone cancer	0.000481	0.00294	CcSEcCtD
Levetiracetam—Anorexia—Cisplatin—bone cancer	0.00048	0.00294	CcSEcCtD
Levetiracetam—Affect lability—Doxorubicin—bone cancer	0.00048	0.00294	CcSEcCtD
Levetiracetam—Pancreatitis—Methotrexate—bone cancer	0.000477	0.00292	CcSEcCtD
Levetiracetam—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.000474	0.0029	CcSEcCtD
Levetiracetam—Nasopharyngitis—Epirubicin—bone cancer	0.000471	0.00288	CcSEcCtD
Levetiracetam—Face oedema—Doxorubicin—bone cancer	0.00047	0.00288	CcSEcCtD
Levetiracetam—Muscular weakness—Epirubicin—bone cancer	0.000464	0.00284	CcSEcCtD
Levetiracetam—Pancytopenia—Methotrexate—bone cancer	0.000462	0.00283	CcSEcCtD
Levetiracetam—Mood swings—Doxorubicin—bone cancer	0.000461	0.00282	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000459	0.00281	CcSEcCtD
Levetiracetam—Ataxia—Doxorubicin—bone cancer	0.000458	0.0028	CcSEcCtD
Levetiracetam—Asthma—Epirubicin—bone cancer	0.000455	0.00279	CcSEcCtD
Levetiracetam—Influenza—Epirubicin—bone cancer	0.000455	0.00279	CcSEcCtD
Levetiracetam—Neutropenia—Methotrexate—bone cancer	0.000455	0.00278	CcSEcCtD
Levetiracetam—Dehydration—Doxorubicin—bone cancer	0.000453	0.00277	CcSEcCtD
Levetiracetam—Paraesthesia—Cisplatin—bone cancer	0.000452	0.00277	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Methotrexate—bone cancer	0.000452	0.00277	CcSEcCtD
Levetiracetam—Eosinophilia—Epirubicin—bone cancer	0.000451	0.00276	CcSEcCtD
Levetiracetam—Liver function test abnormal—Doxorubicin—bone cancer	0.00045	0.00275	CcSEcCtD
Levetiracetam—Pancreatitis—Epirubicin—bone cancer	0.000446	0.00273	CcSEcCtD
Levetiracetam—Abdominal pain upper—Doxorubicin—bone cancer	0.000445	0.00272	CcSEcCtD
Levetiracetam—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000439	0.00269	CcSEcCtD
Levetiracetam—Decreased appetite—Cisplatin—bone cancer	0.000438	0.00268	CcSEcCtD
Levetiracetam—Bronchitis—Epirubicin—bone cancer	0.000438	0.00268	CcSEcCtD
Levetiracetam—Nasopharyngitis—Doxorubicin—bone cancer	0.000436	0.00267	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Cisplatin—bone cancer	0.000435	0.00266	CcSEcCtD
Levetiracetam—Infestation—Methotrexate—bone cancer	0.000434	0.00265	CcSEcCtD
Levetiracetam—Infestation NOS—Methotrexate—bone cancer	0.000434	0.00265	CcSEcCtD
Levetiracetam—Drowsiness—Methotrexate—bone cancer	0.000434	0.00265	CcSEcCtD
Levetiracetam—Depression—Methotrexate—bone cancer	0.000432	0.00265	CcSEcCtD
Levetiracetam—Pancytopenia—Epirubicin—bone cancer	0.000432	0.00265	CcSEcCtD
Levetiracetam—Pain—Cisplatin—bone cancer	0.000431	0.00264	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.00043	0.00263	CcSEcCtD
Levetiracetam—Muscular weakness—Doxorubicin—bone cancer	0.00043	0.00263	CcSEcCtD
Levetiracetam—Neutropenia—Epirubicin—bone cancer	0.000426	0.0026	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Epirubicin—bone cancer	0.000423	0.00259	CcSEcCtD
Levetiracetam—Stomatitis—Methotrexate—bone cancer	0.000423	0.00259	CcSEcCtD
Levetiracetam—Conjunctivitis—Methotrexate—bone cancer	0.000421	0.00258	CcSEcCtD
Levetiracetam—Influenza—Doxorubicin—bone cancer	0.000421	0.00258	CcSEcCtD
Levetiracetam—Asthma—Doxorubicin—bone cancer	0.000421	0.00258	CcSEcCtD
Levetiracetam—Eosinophilia—Doxorubicin—bone cancer	0.000417	0.00255	CcSEcCtD
Levetiracetam—Feeling abnormal—Cisplatin—bone cancer	0.000415	0.00254	CcSEcCtD
Levetiracetam—Weight increased—Epirubicin—bone cancer	0.000414	0.00254	CcSEcCtD
Levetiracetam—Pancreatitis—Doxorubicin—bone cancer	0.000413	0.00253	CcSEcCtD
Levetiracetam—Weight decreased—Epirubicin—bone cancer	0.000412	0.00252	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Methotrexate—bone cancer	0.00041	0.00251	CcSEcCtD
Levetiracetam—Epistaxis—Methotrexate—bone cancer	0.000409	0.0025	CcSEcCtD
Levetiracetam—Drowsiness—Epirubicin—bone cancer	0.000406	0.00248	CcSEcCtD
Levetiracetam—Infestation—Epirubicin—bone cancer	0.000406	0.00248	CcSEcCtD
Levetiracetam—Infestation NOS—Epirubicin—bone cancer	0.000406	0.00248	CcSEcCtD
Levetiracetam—Bronchitis—Doxorubicin—bone cancer	0.000405	0.00248	CcSEcCtD
Levetiracetam—Agranulocytosis—Methotrexate—bone cancer	0.000405	0.00248	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000402	0.00246	CcSEcCtD
Levetiracetam—Pancytopenia—Doxorubicin—bone cancer	0.0004	0.00245	CcSEcCtD
Levetiracetam—Body temperature increased—Cisplatin—bone cancer	0.000398	0.00244	CcSEcCtD
Levetiracetam—Stomatitis—Epirubicin—bone cancer	0.000395	0.00242	CcSEcCtD
Levetiracetam—Conjunctivitis—Epirubicin—bone cancer	0.000394	0.00241	CcSEcCtD
Levetiracetam—Urinary tract infection—Epirubicin—bone cancer	0.000394	0.00241	CcSEcCtD
Levetiracetam—Neutropenia—Doxorubicin—bone cancer	0.000394	0.00241	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000391	0.0024	CcSEcCtD
Levetiracetam—Hepatitis—Methotrexate—bone cancer	0.000389	0.00238	CcSEcCtD
Levetiracetam—Pharyngitis—Methotrexate—bone cancer	0.000386	0.00236	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Epirubicin—bone cancer	0.000384	0.00235	CcSEcCtD
Levetiracetam—Weight increased—Doxorubicin—bone cancer	0.000383	0.00235	CcSEcCtD
Levetiracetam—Epistaxis—Epirubicin—bone cancer	0.000383	0.00234	CcSEcCtD
Levetiracetam—Weight decreased—Doxorubicin—bone cancer	0.000381	0.00233	CcSEcCtD
Levetiracetam—Sinusitis—Epirubicin—bone cancer	0.000381	0.00233	CcSEcCtD
Levetiracetam—Agranulocytosis—Epirubicin—bone cancer	0.000379	0.00232	CcSEcCtD
Levetiracetam—Infestation NOS—Doxorubicin—bone cancer	0.000375	0.0023	CcSEcCtD
Levetiracetam—Drowsiness—Doxorubicin—bone cancer	0.000375	0.0023	CcSEcCtD
Levetiracetam—Infestation—Doxorubicin—bone cancer	0.000375	0.0023	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000372	0.00228	CcSEcCtD
Levetiracetam—Hypersensitivity—Cisplatin—bone cancer	0.000371	0.00227	CcSEcCtD
Levetiracetam—Erythema multiforme—Methotrexate—bone cancer	0.000368	0.00225	CcSEcCtD
Levetiracetam—Stomatitis—Doxorubicin—bone cancer	0.000366	0.00224	CcSEcCtD
Levetiracetam—Rhinitis—Epirubicin—bone cancer	0.000365	0.00224	CcSEcCtD
Levetiracetam—Urinary tract infection—Doxorubicin—bone cancer	0.000365	0.00223	CcSEcCtD
Levetiracetam—Conjunctivitis—Doxorubicin—bone cancer	0.000365	0.00223	CcSEcCtD
Levetiracetam—Hepatitis—Epirubicin—bone cancer	0.000364	0.00223	CcSEcCtD
Levetiracetam—Eye disorder—Methotrexate—bone cancer	0.000364	0.00223	CcSEcCtD
Levetiracetam—Asthenia—Cisplatin—bone cancer	0.000362	0.00221	CcSEcCtD
Levetiracetam—Pharyngitis—Epirubicin—bone cancer	0.000362	0.00221	CcSEcCtD
Levetiracetam—Connective tissue disorder—Epirubicin—bone cancer	0.000358	0.00219	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Doxorubicin—bone cancer	0.000355	0.00217	CcSEcCtD
Levetiracetam—Epistaxis—Doxorubicin—bone cancer	0.000354	0.00217	CcSEcCtD
Levetiracetam—Sinusitis—Doxorubicin—bone cancer	0.000352	0.00216	CcSEcCtD
Levetiracetam—Immune system disorder—Methotrexate—bone cancer	0.000352	0.00215	CcSEcCtD
Levetiracetam—Mediastinal disorder—Methotrexate—bone cancer	0.000351	0.00215	CcSEcCtD
Levetiracetam—Agranulocytosis—Doxorubicin—bone cancer	0.00035	0.00214	CcSEcCtD
Levetiracetam—Diarrhoea—Cisplatin—bone cancer	0.000345	0.00211	CcSEcCtD
Levetiracetam—Erythema multiforme—Epirubicin—bone cancer	0.000344	0.00211	CcSEcCtD
Levetiracetam—Alopecia—Methotrexate—bone cancer	0.000344	0.00211	CcSEcCtD
Levetiracetam—Mental disorder—Methotrexate—bone cancer	0.000341	0.00209	CcSEcCtD
Levetiracetam—Eye disorder—Epirubicin—bone cancer	0.00034	0.00208	CcSEcCtD
Levetiracetam—Malnutrition—Methotrexate—bone cancer	0.000339	0.00207	CcSEcCtD
Levetiracetam—Rhinitis—Doxorubicin—bone cancer	0.000338	0.00207	CcSEcCtD
Levetiracetam—Hepatitis—Doxorubicin—bone cancer	0.000337	0.00206	CcSEcCtD
Levetiracetam—Pharyngitis—Doxorubicin—bone cancer	0.000334	0.00205	CcSEcCtD
Levetiracetam—Connective tissue disorder—Doxorubicin—bone cancer	0.000331	0.00203	CcSEcCtD
Levetiracetam—Immune system disorder—Epirubicin—bone cancer	0.000329	0.00201	CcSEcCtD
Levetiracetam—Mediastinal disorder—Epirubicin—bone cancer	0.000328	0.00201	CcSEcCtD
Levetiracetam—Back pain—Methotrexate—bone cancer	0.000328	0.00201	CcSEcCtD
Levetiracetam—Alopecia—Epirubicin—bone cancer	0.000322	0.00197	CcSEcCtD
Levetiracetam—Vomiting—Cisplatin—bone cancer	0.00032	0.00196	CcSEcCtD
Levetiracetam—Vision blurred—Methotrexate—bone cancer	0.000319	0.00195	CcSEcCtD
Levetiracetam—Mental disorder—Epirubicin—bone cancer	0.000319	0.00195	CcSEcCtD
Levetiracetam—Erythema multiforme—Doxorubicin—bone cancer	0.000319	0.00195	CcSEcCtD
Levetiracetam—Rash—Cisplatin—bone cancer	0.000318	0.00194	CcSEcCtD
Levetiracetam—Dermatitis—Cisplatin—bone cancer	0.000317	0.00194	CcSEcCtD
Levetiracetam—Malnutrition—Epirubicin—bone cancer	0.000317	0.00194	CcSEcCtD
Levetiracetam—Eye disorder—Doxorubicin—bone cancer	0.000315	0.00193	CcSEcCtD
Levetiracetam—Tension—Epirubicin—bone cancer	0.000311	0.0019	CcSEcCtD
Levetiracetam—Nervousness—Epirubicin—bone cancer	0.000308	0.00189	CcSEcCtD
Levetiracetam—Back pain—Epirubicin—bone cancer	0.000307	0.00188	CcSEcCtD
Levetiracetam—Immune system disorder—Doxorubicin—bone cancer	0.000304	0.00186	CcSEcCtD
Levetiracetam—Vertigo—Methotrexate—bone cancer	0.000304	0.00186	CcSEcCtD
Levetiracetam—Mediastinal disorder—Doxorubicin—bone cancer	0.000304	0.00186	CcSEcCtD
Levetiracetam—Leukopenia—Methotrexate—bone cancer	0.000303	0.00186	CcSEcCtD
Levetiracetam—Nausea—Cisplatin—bone cancer	0.000299	0.00183	CcSEcCtD
Levetiracetam—Vision blurred—Epirubicin—bone cancer	0.000299	0.00183	CcSEcCtD
Levetiracetam—Alopecia—Doxorubicin—bone cancer	0.000298	0.00182	CcSEcCtD
Levetiracetam—Cough—Methotrexate—bone cancer	0.000296	0.00181	CcSEcCtD
Levetiracetam—Mental disorder—Doxorubicin—bone cancer	0.000295	0.00181	CcSEcCtD
Levetiracetam—Convulsion—Methotrexate—bone cancer	0.000294	0.0018	CcSEcCtD
Levetiracetam—Malnutrition—Doxorubicin—bone cancer	0.000293	0.0018	CcSEcCtD
Levetiracetam—Agitation—Epirubicin—bone cancer	0.000291	0.00178	CcSEcCtD
Levetiracetam—Chest pain—Methotrexate—bone cancer	0.000288	0.00177	CcSEcCtD
Levetiracetam—Myalgia—Methotrexate—bone cancer	0.000288	0.00177	CcSEcCtD
Levetiracetam—Arthralgia—Methotrexate—bone cancer	0.000288	0.00177	CcSEcCtD
Levetiracetam—Tension—Doxorubicin—bone cancer	0.000288	0.00176	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000286	0.00175	CcSEcCtD
Levetiracetam—Nervousness—Doxorubicin—bone cancer	0.000285	0.00174	CcSEcCtD
Levetiracetam—Vertigo—Epirubicin—bone cancer	0.000285	0.00174	CcSEcCtD
Levetiracetam—Leukopenia—Epirubicin—bone cancer	0.000284	0.00174	CcSEcCtD
Levetiracetam—Back pain—Doxorubicin—bone cancer	0.000284	0.00174	CcSEcCtD
Levetiracetam—Confusional state—Methotrexate—bone cancer	0.000279	0.00171	CcSEcCtD
Levetiracetam—Cough—Epirubicin—bone cancer	0.000277	0.00169	CcSEcCtD
Levetiracetam—Vision blurred—Doxorubicin—bone cancer	0.000276	0.00169	CcSEcCtD
Levetiracetam—Convulsion—Epirubicin—bone cancer	0.000275	0.00168	CcSEcCtD
Levetiracetam—Infection—Methotrexate—bone cancer	0.000275	0.00168	CcSEcCtD
Levetiracetam—Nervous system disorder—Methotrexate—bone cancer	0.000271	0.00166	CcSEcCtD
Levetiracetam—Thrombocytopenia—Methotrexate—bone cancer	0.000271	0.00166	CcSEcCtD
Levetiracetam—Myalgia—Epirubicin—bone cancer	0.00027	0.00165	CcSEcCtD
Levetiracetam—Chest pain—Epirubicin—bone cancer	0.00027	0.00165	CcSEcCtD
Levetiracetam—Arthralgia—Epirubicin—bone cancer	0.00027	0.00165	CcSEcCtD
Levetiracetam—Agitation—Doxorubicin—bone cancer	0.00027	0.00165	CcSEcCtD
Levetiracetam—Anxiety—Epirubicin—bone cancer	0.000269	0.00165	CcSEcCtD
Levetiracetam—Skin disorder—Methotrexate—bone cancer	0.000269	0.00164	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000268	0.00164	CcSEcCtD
Levetiracetam—Vertigo—Doxorubicin—bone cancer	0.000264	0.00161	CcSEcCtD
Levetiracetam—Anorexia—Methotrexate—bone cancer	0.000264	0.00161	CcSEcCtD
Levetiracetam—Leukopenia—Doxorubicin—bone cancer	0.000263	0.00161	CcSEcCtD
Levetiracetam—Confusional state—Epirubicin—bone cancer	0.000261	0.0016	CcSEcCtD
Levetiracetam—Infection—Epirubicin—bone cancer	0.000257	0.00157	CcSEcCtD
Levetiracetam—Cough—Doxorubicin—bone cancer	0.000256	0.00157	CcSEcCtD
Levetiracetam—Convulsion—Doxorubicin—bone cancer	0.000254	0.00156	CcSEcCtD
Levetiracetam—Nervous system disorder—Epirubicin—bone cancer	0.000254	0.00155	CcSEcCtD
Levetiracetam—Thrombocytopenia—Epirubicin—bone cancer	0.000253	0.00155	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000252	0.00154	CcSEcCtD
Levetiracetam—Skin disorder—Epirubicin—bone cancer	0.000251	0.00154	CcSEcCtD
Levetiracetam—Insomnia—Methotrexate—bone cancer	0.00025	0.00153	CcSEcCtD
Levetiracetam—Myalgia—Doxorubicin—bone cancer	0.00025	0.00153	CcSEcCtD
Levetiracetam—Chest pain—Doxorubicin—bone cancer	0.00025	0.00153	CcSEcCtD
Levetiracetam—Arthralgia—Doxorubicin—bone cancer	0.00025	0.00153	CcSEcCtD
Levetiracetam—Anxiety—Doxorubicin—bone cancer	0.000249	0.00152	CcSEcCtD
Levetiracetam—Paraesthesia—Methotrexate—bone cancer	0.000248	0.00152	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000248	0.00152	CcSEcCtD
Levetiracetam—Anorexia—Epirubicin—bone cancer	0.000247	0.00151	CcSEcCtD
Levetiracetam—Somnolence—Methotrexate—bone cancer	0.000246	0.0015	CcSEcCtD
Levetiracetam—Dyspepsia—Methotrexate—bone cancer	0.000243	0.00149	CcSEcCtD
Levetiracetam—Confusional state—Doxorubicin—bone cancer	0.000241	0.00148	CcSEcCtD
Levetiracetam—Decreased appetite—Methotrexate—bone cancer	0.00024	0.00147	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Methotrexate—bone cancer	0.000239	0.00146	CcSEcCtD
Levetiracetam—Fatigue—Methotrexate—bone cancer	0.000238	0.00146	CcSEcCtD
Levetiracetam—Infection—Doxorubicin—bone cancer	0.000238	0.00146	CcSEcCtD
Levetiracetam—Pain—Methotrexate—bone cancer	0.000236	0.00145	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000236	0.00144	CcSEcCtD
Levetiracetam—Nervous system disorder—Doxorubicin—bone cancer	0.000235	0.00144	CcSEcCtD
Levetiracetam—Thrombocytopenia—Doxorubicin—bone cancer	0.000234	0.00144	CcSEcCtD
Levetiracetam—Insomnia—Epirubicin—bone cancer	0.000234	0.00143	CcSEcCtD
Levetiracetam—Skin disorder—Doxorubicin—bone cancer	0.000233	0.00142	CcSEcCtD
Levetiracetam—Paraesthesia—Epirubicin—bone cancer	0.000232	0.00142	CcSEcCtD
Levetiracetam—Somnolence—Epirubicin—bone cancer	0.00023	0.00141	CcSEcCtD
Levetiracetam—Anorexia—Doxorubicin—bone cancer	0.000228	0.0014	CcSEcCtD
Levetiracetam—Feeling abnormal—Methotrexate—bone cancer	0.000228	0.00139	CcSEcCtD
Levetiracetam—Dyspepsia—Epirubicin—bone cancer	0.000228	0.00139	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Methotrexate—bone cancer	0.000226	0.00138	CcSEcCtD
Levetiracetam—Decreased appetite—Epirubicin—bone cancer	0.000225	0.00138	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Epirubicin—bone cancer	0.000223	0.00137	CcSEcCtD
Levetiracetam—Fatigue—Epirubicin—bone cancer	0.000223	0.00137	CcSEcCtD
Levetiracetam—Constipation—Epirubicin—bone cancer	0.000221	0.00135	CcSEcCtD
Levetiracetam—Pain—Epirubicin—bone cancer	0.000221	0.00135	CcSEcCtD
Levetiracetam—Body temperature increased—Methotrexate—bone cancer	0.000219	0.00134	CcSEcCtD
Levetiracetam—Abdominal pain—Methotrexate—bone cancer	0.000219	0.00134	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000218	0.00134	CcSEcCtD
Levetiracetam—Insomnia—Doxorubicin—bone cancer	0.000217	0.00133	CcSEcCtD
Levetiracetam—Paraesthesia—Doxorubicin—bone cancer	0.000215	0.00132	CcSEcCtD
Levetiracetam—Feeling abnormal—Epirubicin—bone cancer	0.000213	0.00131	CcSEcCtD
Levetiracetam—Somnolence—Doxorubicin—bone cancer	0.000213	0.0013	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Epirubicin—bone cancer	0.000212	0.0013	CcSEcCtD
Levetiracetam—Dyspepsia—Doxorubicin—bone cancer	0.000211	0.00129	CcSEcCtD
Levetiracetam—Decreased appetite—Doxorubicin—bone cancer	0.000208	0.00127	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000207	0.00127	CcSEcCtD
Levetiracetam—Fatigue—Doxorubicin—bone cancer	0.000206	0.00126	CcSEcCtD
Levetiracetam—Constipation—Doxorubicin—bone cancer	0.000205	0.00125	CcSEcCtD
Levetiracetam—Pain—Doxorubicin—bone cancer	0.000205	0.00125	CcSEcCtD
Levetiracetam—Body temperature increased—Epirubicin—bone cancer	0.000205	0.00125	CcSEcCtD
Levetiracetam—Abdominal pain—Epirubicin—bone cancer	0.000205	0.00125	CcSEcCtD
Levetiracetam—Hypersensitivity—Methotrexate—bone cancer	0.000204	0.00125	CcSEcCtD
Levetiracetam—Asthenia—Methotrexate—bone cancer	0.000198	0.00121	CcSEcCtD
Levetiracetam—Feeling abnormal—Doxorubicin—bone cancer	0.000197	0.00121	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Doxorubicin—bone cancer	0.000196	0.0012	CcSEcCtD
Levetiracetam—Pruritus—Methotrexate—bone cancer	0.000196	0.0012	CcSEcCtD
Levetiracetam—Hypersensitivity—Epirubicin—bone cancer	0.000191	0.00117	CcSEcCtD
Levetiracetam—Abdominal pain—Doxorubicin—bone cancer	0.000189	0.00116	CcSEcCtD
Levetiracetam—Body temperature increased—Doxorubicin—bone cancer	0.000189	0.00116	CcSEcCtD
Levetiracetam—Diarrhoea—Methotrexate—bone cancer	0.000189	0.00116	CcSEcCtD
Levetiracetam—Asthenia—Epirubicin—bone cancer	0.000186	0.00114	CcSEcCtD
Levetiracetam—Pruritus—Epirubicin—bone cancer	0.000183	0.00112	CcSEcCtD
Levetiracetam—Dizziness—Methotrexate—bone cancer	0.000183	0.00112	CcSEcCtD
Levetiracetam—Diarrhoea—Epirubicin—bone cancer	0.000177	0.00108	CcSEcCtD
Levetiracetam—Hypersensitivity—Doxorubicin—bone cancer	0.000176	0.00108	CcSEcCtD
Levetiracetam—Vomiting—Methotrexate—bone cancer	0.000176	0.00108	CcSEcCtD
Levetiracetam—Rash—Methotrexate—bone cancer	0.000174	0.00107	CcSEcCtD
Levetiracetam—Dermatitis—Methotrexate—bone cancer	0.000174	0.00107	CcSEcCtD
Levetiracetam—Headache—Methotrexate—bone cancer	0.000173	0.00106	CcSEcCtD
Levetiracetam—Asthenia—Doxorubicin—bone cancer	0.000172	0.00105	CcSEcCtD
Levetiracetam—Dizziness—Epirubicin—bone cancer	0.000171	0.00105	CcSEcCtD
Levetiracetam—Pruritus—Doxorubicin—bone cancer	0.000169	0.00104	CcSEcCtD
Levetiracetam—Vomiting—Epirubicin—bone cancer	0.000165	0.00101	CcSEcCtD
Levetiracetam—Nausea—Methotrexate—bone cancer	0.000164	0.00101	CcSEcCtD
Levetiracetam—Diarrhoea—Doxorubicin—bone cancer	0.000164	0.001	CcSEcCtD
Levetiracetam—Rash—Epirubicin—bone cancer	0.000163	0.000999	CcSEcCtD
Levetiracetam—Dermatitis—Epirubicin—bone cancer	0.000163	0.000998	CcSEcCtD
Levetiracetam—Headache—Epirubicin—bone cancer	0.000162	0.000992	CcSEcCtD
Levetiracetam—Dizziness—Doxorubicin—bone cancer	0.000158	0.000969	CcSEcCtD
Levetiracetam—Nausea—Epirubicin—bone cancer	0.000154	0.000941	CcSEcCtD
Levetiracetam—Vomiting—Doxorubicin—bone cancer	0.000152	0.000932	CcSEcCtD
Levetiracetam—Rash—Doxorubicin—bone cancer	0.000151	0.000924	CcSEcCtD
Levetiracetam—Dermatitis—Doxorubicin—bone cancer	0.000151	0.000923	CcSEcCtD
Levetiracetam—Headache—Doxorubicin—bone cancer	0.00015	0.000918	CcSEcCtD
Levetiracetam—Nausea—Doxorubicin—bone cancer	0.000142	0.000871	CcSEcCtD
